D.Western Therapeutics Institute, Inc.

4576・Growth Market・Pharmaceuticals

4576・Growth Market・Pharmaceuticals

D.Western Therapeutics Institute, Inc.4576

Reference Indicators

Market Cap

43¥100M

P/E (Forecast)

—

P/B

3.0x

Dividend Yield (Forecast)

0.00%

ROE

-44.1%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Net Sales	414	448	428	471	387
Cost of Sales	20	27	36	46	38
Gross Profit	394	420	391	424	348
SG&A Expenses	565	726	1,190	1,634	968
Operating Income	-171	-305	-798	-1,209	-619
Non-operating Income	17	38	6	2	10
Non-operating Expenses	5	28	4	20	20
Ordinary Income	-159	-295	-796	-1,228	-630
Extraordinary Losses	—	144	30	60	—
Pre-tax Income	-159	-440	-826	-1,288	-630
Income Taxes	1	1	1	1	1
Net Income	-148	-429	-812	-1,290	-632
EBITDA	-126	-259	-749	-1,160	-572
Gross Margin	95.1%	93.8%	91.4%	90.1%	90.0%
Operating Margin	-41.4%	-68.3%	-186.4%	-256.5%	-159.9%
ROA	-6.0%	-14.5%	-34.2%	-77.3%	-29.1%
ROE	-7.4%	-23.1%	-63.5%	-176.2%	-44.1%

Disclaimer